Literature DB >> 10376748

National Cancer Data Base report on cancer of the head and neck: acinic cell carcinoma.

H T Hoffman1, L H Karnell, R A Robinson, J A Pinkston, H R Menck.   

Abstract

BACKGROUND: Management of acinic cell carcinoma is based on reports of small numbers of cases accrued over several decades.
METHODS: The National Cancer Data Base (NCDB) identified 1353 cases of acinic cell carcinoma of the head and neck for the years 1985 to 1995. Chi square analyses of selected contingency tables and Wilcoxon regression analyses of selected survival stratifications are presented.
RESULTS: Five-year survival was 83.3% (observed) and 91.4% (disease specific). Worse survival was associated with high grade (p < .0001), age greater or equal to 30 years (p = .0055), and the presence of metastatic disease (p < .0001).
CONCLUSIONS: An aggressive subset of acinic cell carcinoma which is characterized by high grade and advanced stage rarely occurs in patients younger than 30 years old. Although better outcome was not statistically demonstrated for combined therapy, surgery with irradiation is the most common management in the United States for cases with regional metastases, high grade, and microscopic positive margins.

Entities:  

Mesh:

Year:  1999        PMID: 10376748     DOI: 10.1002/(sici)1097-0347(199907)21:4<297::aid-hed2>3.0.co;2-r

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  29 in total

Review 1.  Salivary acinic cell carcinoma: reappraisal and update.

Authors:  V Vander Poorten; A Triantafyllou; L D R Thompson; J Bishop; E Hauben; J Hunt; A Skalova; G Stenman; R P Takes; D R Gnepp; H Hellquist; B Wenig; D Bell; A Rinaldo; A Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-12-19       Impact factor: 2.503

2.  [On the diagnosis and treatment of parotid gland tumors. Results of a nationwide survey of ENT hospitals in Germany].

Authors:  S F Preuss; O Guntinas-Lichius
Journal:  HNO       Date:  2006-11       Impact factor: 1.284

3.  Most nonparotid "acinic cell carcinomas" represent mammary analog secretory carcinomas.

Authors:  Justin A Bishop; Raluca Yonescu; Denise Batista; David W Eisele; William H Westra
Journal:  Am J Surg Pathol       Date:  2013-07       Impact factor: 6.394

4.  Acinic Cell Carcinoma of the Parotid Gland with Four Morphological Features.

Authors:  David S Rosero; Ramiro Alvarez; Paula Gambó; María Alastuey; Alberto Valero; Nerea Torrecilla; A Belén Roche; Sara Simón
Journal:  Iran J Pathol       Date:  2016

5.  Parotid carcinoma: Current diagnostic workup and treatment.

Authors:  Vincent L M Vander Poorten; Francis Marchal; Sandra Nuyts; Paul M J Clement
Journal:  Indian J Surg Oncol       Date:  2010-11-21

6.  Postoperative [¹²⁵I] seed brachytherapy in the treatment of acinic cell carcinoma of the parotid gland: with associated risk factors.

Authors:  Ming-Hui Mao; Jian-Guo Zhang; Jie Zhang; Lei Zheng; Shu-Ming Liu; Ming-Wei Huang; Yan Shi
Journal:  Strahlenther Onkol       Date:  2014-04-29       Impact factor: 3.621

7.  Acinic cell carcinoma in pregnancy: a case report and review of the literature.

Authors:  Nabil N Al-Zaher; Amani A Obeid
Journal:  J Med Case Rep       Date:  2011-03-04

Review 8.  Salivary gland carcinomas.

Authors:  Tobias Ettl; Stephan Schwarz-Furlan; Martin Gosau; Torsten E Reichert
Journal:  Oral Maxillofac Surg       Date:  2012-07-29

9.  Dedifferentiated acinic cell tumour: the harlequin of salivary gland neoplasms--an unusual variant.

Authors:  Anshu Jain; Kiran Alam; Aroonima Misra; Veena Maheshwari
Journal:  BMJ Case Rep       Date:  2013-05-27

10.  Skull base involvement by acinic cell carcinoma of the parotid gland.

Authors:  Joseph T Breen; Matthew L Carlson; Michael J Link; Eric J Moore; Brian A Neff; Colin L W Driscoll
Journal:  J Neurol Surg B Skull Base       Date:  2012-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.